SCHEMBL785145

SCHEMBL785145

O=C(Cc1ccccc1)NC1CCc2ccc(C(=O)O)cc21

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.48
DRD2 P14416 1/20 0.48
HTR2A P28223 1/20 0.48
KCNH2 Q12809 1/20 0.48
ALDH1A1 P00352 2/20 0.47
ROCK2 O75116 2/20 0.47
ROCK1 Q13464 2/20 0.47
EPHX2 P34913 3/20 0.46
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
TAOK3 Q9H2K8 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL785755 1.00 HTR1A (0.48) HTR1ADRD2HTR2AKCNH2ALDH1A1
SCHEMBL803551 0.88 ALDH1A1 (0.52) HTR1ADRD2HTR2AKCNH2ALDH1A1
SCHEMBL784802 0.84 P2RX7 (0.48) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL2818832 0.84 RAB9A (0.46) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL2817956 0.84 MEN1 (0.46) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL2817962 0.84 MEN1 (0.46) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL2818836 0.84 RAB9A (0.46) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL785553 0.84 P2RX7 (0.48) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL784599 0.84 HTT (0.62) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL784469 0.84 HTT (0.62) ALDH1A1PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 HTR1A 94/4885DRD2 64/4885HTR2A 475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.